Washington Trust Advisors’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6K Hold
175
– – ﹤0.01% 616
2026
Q1
$1.48K Hold
175
– – ﹤0.01% 603
2025
Q4
$1.98K Hold
175
– – ﹤0.01% 577
2025
Q3
$2.63K Hold
175
– – ﹤0.01% 651
2025
Q2
$2.47K Hold
175
– – ﹤0.01% 600
2025
Q1
$4.21K Hold
175
– – ﹤0.01% 565
2024
Q4
$6.54K Hold
175
– – ﹤0.01% 535
2024
Q3
$8.74K Sell
175
-30
-15% -$1.17K ﹤0.01% 497
2024
Q2
$7.12K Hold
205
– – ﹤0.01% 512
2024
Q1
$11.2K Hold
205
– – ﹤0.01% 465
2023
Q4
$8.77K Hold
205
– – ﹤0.01% 500
2023
Q3
$5.33K Hold
205
– – ﹤0.01% 543
2023
Q2
$4.9K Hold
205
– – ﹤0.01% 545
2023
Q1
$2.8K Hold
205
– – ﹤0.01% 702
2022
Q4
$2.85K Sell
205
-214
-51% -$3.02K ﹤0.01% 694
2022
Q3
$62K Buy
+419
New +$3.04K 0.01% 352

Other funds holding BHVN

Washington Trust Advisors's BHVN Position: Q2 2026 in Review

Washington Trust Advisors held its Biohaven (BHVN) position steady in Q2 2026 at 175 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Washington Trust Advisors first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $62K in Q3 2022. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Washington Trust Advisors held 175 shares of Biohaven worth $2.6K as of Q2 2026.
  • Washington Trust Advisors left its Biohaven share count unchanged in Q2 2026.
  • Biohaven made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #616 holding.
  • Washington Trust Advisors first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
  • Washington Trust Advisors's Biohaven position peaked at $62K in Q3 2022.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.